Skip to main content
. 2016 Nov 18;12(4):344–352. doi: 10.1016/j.ajps.2016.09.008

Fig. 10.

Fig. 10

Plasma concentration–time curves for the AZL nanosuspension (Nano1) and physical mixture after oral administration in rats (mean ± SD, n = 6).